Ann Ehrenhofer-Murray is a professor of molecular cell biology at Humboldt-Universität zu Berlin. Ann studies the mechanisms of gene regulation by chromatin and RNA modifications. She initiated her studies on epigenetic gene silencing and histone acetylation as a postdoc at the University of California, Berkeley and expanded the work as an independent group leader at the Max-Planck-Institute for Molecular Genetics in Berlin. After professorships in genetics at the universities of Giessen and Duisburg-Essen, she returned to Berlin in 2013. Next to investigating the regulation of heterochromatin and centromeres through histone modifications, she more recently is studying the cross-talk of (t)RNA modifications and how they modulate protein translation.
M. A. Faghihi, M.D., Ph.D., is an Assistant Professor at The Department of Psychiatry & Behavioral Sciences at the University of Miami, Miller School of Medicine. Dr. Faghihi will also serve as a member of the Center for Therapeutic Innovation at the John P. Hussman Institute for Human Genomics. He received his medical doctorate (M.D.) degree from Shiraz University of Medical Sciences, Iran in 1994. He received his Ph.D. degree in Biomedical Sciences at the Karolinska Institute, Stockholm, Sweden in 2009. He served as a Senior Staff Scientist at the Department of Neuroscience at the Scripps Research Institute, Florida, before joining University of Miami. Dr. Faghihi is an expert in the field of RNA genetics, interested in non-coding RNA, particularly natural antisense transcripts and their involvement in neurological disorders such as Alzheimer's disease, Parkinson's disease, Multiple Sclerosis and Fragile X Syndrome.
Professor Stunnenberg is the Research Director of RIMLS/Faculty of Science, and coordinator of the EU FP7 High Impact Project BLUEPRINT (the BLUEPRINT of Haematopoietic Epigenomes) that runs from 2011-2016 (www.blueprint-epigenome.eu) and currently he is Chair of the International Scientific Steering Committee of the International Human Epigenome Consortium (IHEC).
Head of the genetic diagnostic lab, National Institute for Genetic Engineering and Biotechnology. PhD from Gothenburg University. Winner of ISSCO price 2014 as best biology researcher. In slamic counties. Winner of best Researcher in medical biotechnolgy in 2015 in Iran. More than 200 publications and 17 books.
Achim Leutz is a Professor of Developmental Biology and Oncology at the Humboldt University zu Berlin and a scientific group leader at the Max-Delbrueck-Center for Molecular Medicine (MDC). He received his doctoral degree from the University of Heidelberg, Germany (1986) and after postdoctoral research in the US, staff scientist at the EMBL, and scientific group leader at the Center of Molecular Biology (University of Heidelberg), he joined the MDC in 1994. He initiated the International PhD Program of the MDC together with the Faculty of Biology (since 2002), was appointed EMBO-Member (2005) and received the German Cancer Award (2007). Areas of expertise are molecular mechanisms in hematopoietic cell fate decisions and leukemogenesis, lymphoid-myeloid transdifferentiation, gene regulation and epigenetics
Lucia Altucci is Associate Professor of General Pathology at University of Naples 2, where she is teaches the causal mechanisms of diseases with a focus on tumorigenesis to medical students, technicians and biotechnologists.Since 2014 she is collaborating with AVA and ANVUR taking part to the evaluating committee of Research centers, Universities and quality of researchers. She is Editor of the IJBCB (Elsevier) and of J Clinical Epigenetics (Biomed Central). She is part of many International committees for the evaluation of research in EU and outside.Lucia won the Presidential gold medal for her studies on Epigenetics & Cancer in 2010 and the price for cancer research given from the prestigious ‘Accademia dei Lincei’ in 2005.Her research focuses on innovative therapeutic strategies against cancer, (epi)drug discovery and development, identification of pathogenesis of diseases with a focus on cancer (epi)genome alterations.She is one of the founding members of the companies Mesogenics and Epi-C.v.
Dr Ghader Mirzaghaderi was born in 1974 in Bokan, Iran. He obtained his BSc degree (1998) in the field of Agronomy and Plant Breeding from Urmia University, his M.Sc. degree (2001) in Genetics and Plant Breeding from Tarbiat Modares University, and his Ph.D. degree (2008) in Plant Breeding from Tarbiat Modares University. Dr Mirzaghaderi joined University of Kurdistan, Sanandaj, as academic staff in 2009 and am now serve as an associate professor in Agronomy and Plant Breeding Department, Faculty of Agriculture. His research interest areas are polyploidy, meiosis and wheat-alien interspecific hybridization.
Priv.Doz. Dr. E. Korsching is PI of the Cancer & Complex Systems Research Group at the Institute of Bioinformatics of the University Hospital of Muenster. The studies in chemistry and biochemistry were brought to perfection in a PhD thesis on extra cellular matrix research. The present work focus has evolved from wet lab based research in cell and molecular biology (in a clinical setting) towards theoretical methods in biology. The foundations of the present work and the focus on clinical questions was established during the long standing research work in the pathology. The commitment to interdisciplinarity in research resulted in an ever growing research effort in theoretical biology, stimulated by the wealth of already existing mathematical and physical concepts. These concepts has been a source of inspiration in concrete research efforts in the field of breast and bone cancers. The present research program is centered around the biological reaction networks and how they form this robust and adaptive multi-cellular system. Beside these basic research efforts , which rely on simulation studies and analysis of array/sequence data sets, we apply those mechanistic insights to understand cancer formation and progression. Some further clinical projects focus on the definition of biological marker panels and quality standard.
Stephan Züchner, M.D., Ph.D., is a Professor and Chair for the Dr. John T. Macdonald Foundation Department of Human Genetics. He is a trained neurologist and molecular geneticist with research interests in identifying genetic variation associated with disease. His lab has identified several genes for Mendelian neurodegenerative disorders and also evaluated risk factors for complex genetic conditions, including Alzheimer disease, Parkinson disease, and obsessive-compulsive disorder. His lab is amongst the pioneering groups that have promoted genome sequencing methods for disease gene identification in humans, mice, and drosophilia. He is currently pursuing large-scale exome and genome analysis in multiple neurodegenerative disorders and develops innovative new software tools that allow real time shared analysis of large amounts of genomic data.
Dr. vahid khoddami,Vahid got his BS dergree in Medical Lab Sciences from Tehran University of Medical Sciences (Iran) and his MSc degree in Medical Biotechnology from Tarbiat Modares Univesity. In his MSc Vahid worked on implementation of RNAi in breast cancer cells. In 2007 he moved to United States for graduate school and got his PhD degree in Molecular Biology from University of Utah (USA) in 2013. After PhD he spent another year in Utah serving as Postdoctoral fellow at Huntsman Cancer Institute. In his PhD and postdoc in Utah, under the supervision Prof. Bradley cairns (HHMI investigator) he worked on developing novel technologies for transcriptomewide mapping of nucleotide modifications in RNA. In 2014 he moved to Boston to start his second postdoc at Harvard Medical School in the department of Cell Biology under the supervision Prof. Danesh Moazed (HHMI investigator) working on some interesting aspects of heterochromatin biology. In the fall of 2017 Vahid returned back to Iran and joined Royan Institute as an assistant professor. His main research interest is understanding the biological significance as well as clinical implications of RNA modifications and modified RNAs.
Dr. Martin Mascher,Head of the Domestication Genomics research group at the Leibnitz Institute of Plant Genetics and Crop Plant Research (IPK) in Gatersleben, Germany.
Martin Mascher is a group leader at the Leibniz Institute of Plant Genetics and Crop Research (IPK) Gatersleben in Germany. His research is focussed on domestication and adaptation processes and their interaction with genetic diversity in cereal crops and their wild relatives. A mathematician by training, he received his Ph. D. in bioinformatics from
the University of Bielefeld. Martin is interested in applying high-throughput methods in genomics and new computational algorithms to understand the genetic variation in germplasm collections of wild and domesticated plants.
Elahe Elahi is professor at the School of Biology at Tehran University. She received her Bachelor’s degree in Biology from the University of California at Berkeley in 1970, and her PhD from the University of Michigan in 1976. She did post-doctoral work at UCSF (University of California at San Francisco medical school), and returned to Iran just after the revolution at the end of 1979. Her research has been mostly on human medical genetics, but she occasionally diversifies into fields that include barcoding and bioinformatics. She and her colleagues identified FBXO7 as a causative gene of Parkinson’s disease, LTBP2 as a causative gene of primary congenital glaucoma, and CYP27A1 and ST6GALNA5 as causative genes of coronary artery disease by genetic linkage analysis and exome sequencing. Her emphasis has been on neurodegenerative diseases, and is presently trying to identify molecular pathways possibly involved in the etiology of glaucoma.
Prof. Peyvandi received her medical degree from the University of Milan, Italy, is certified in Haematology and was awarded PhDs from the Maastricht University, The Netherlands and the University of Milan, Italy for her research in the field of rare bleeding disorders. As part of her PhD thesis she was research fellow at the Royal Free Hospital, University College London, London, UK in 1997-98 for molecular characterisation of rare bleeding disorders and at the Veteran Administration Hospital, Harvard University, Boston, USA in 1998-99 for in vitro expression studies.
Prof. Peyvandi’s basic and medical science research has focussed on the investigation of molecular mechanisms of coagulation disorders. Her research in the prevalence and mechanism of coagulation disorders aims at developing cost-effective treatment for the widespread treatment of patients. Dr. Peyvandi has authored and co-authored more than 360 scientific publications that have been published across well-known specialised journals (IF of about 1745, H index WoS of 49) and also 18 chapters in various books. Since 1999, she has been invited as an expert speaker at more than 128 national and international meetings and congresses. She has been the successful recipient of more than 40 project grants funded by Italian and International organisations and she was the principal investigator of the Establishment of a European Network of Rare Bleeding Disorders programme. She participates in clinical, educational and research activities in different parts of the world and she was Chair of the International Society of Thrombosis and Haemostasis (ISTH) Scientific and Standardization Committee on Factor VIII, Factor IX and Rare Coagulation Disorders. She is member of the ISTH council, member of the Executive Committee of the World Federation of Hemophilia (WFH), member of the executive committee of the European Association for Haemophilia and Allied Disorders (EAHAD) and member of the Medical Advisory Group of the European Hemophilia Consortium (EHC). In 2014 she was awarded the “Great Hippocrates” that is delivered to Italian medical researcher of the year.
Dr. Masoud Garshasbi received his B.Sc. in Biology from the Ferdowsi University Mashhad, Iran (2001), and his M.Sc. in Human Genetics from the University of Social Welfare and Rehabilitation (USWR), Tehran, Iran (2003). He obtained his Ph.D. (2009) and Post doctoral (2011) in Human Molecular Genetics from Max Planck Institute for Molecular Genetics (MPIMG), Berlin, Germany by working on the genes involved in Intellectual Disability (ID). The outcome of his research was finding several novel genes for some of the inherited disorders. At 2011 he came back to Iran and since then he has been successfully active in both academia and private section. He joined as an assistant professor to the Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. He is founder and head of Medical Genetic Department at the DeNA laboratory, Tehran, Iran. He has also established the Medical Genetics department at the laboratory of Pars hospital, Tehran, Iran (2011-2013). Since 2011 he has been a part-time visiting collaborative member of the laboratory of Masih Daneshvari Hospital, Shahid Beheshti Medical Sciences University. He has published so far more than 40 research papers in peer review high ranking international journals (h-index:22). His main area of research is gene mapping and finding the mechanism behind the genetic disorders. He is a member of Iranian National Elites Foundation (INEF). In 2015 he has been chosen among the first 50 distinguished Iranian researchers by the Iran Saramadane Elmi Federation (ISEF). In 2014 he has been elected as a board member and also secretary of Iranian Society of Medical Genetics (ISMG) for three and half years..
Salvatore Oliviero, PhD
Professor of Molecular Biology at University of Torino
PI of the epigenetic unit at the Italian Institute for Genomic Medicine
Between 1985 and 1988 at EMBL as PhD student he identified and characterized the inflammatory response elements in the acute phase gene. From 1988 to 1992, as post-doctoral fellow at Harvard Medical School mapped the FOS domains required for cellular transformation. From 1992 to 2010 as professor at the University of Siena identified new FOS-target genes involved in tumorigenesis. The most relevant was the identification and cloning of a new lymphangiogenic growth factor (VEGF-D). He described, for the first time, the molecular mechanism by which Myc regulates the elongation step of the transcription: he found that Myc-dependent phosphorylation of H3S10 triggers a cascade of epigenetic modifications that lead to the recruitmentnt of P-TEFb to the promoter. In 2010 moved to the University of Torino and IIGM. His lab is mainly focused on the analysis of epigenetic modifications that regulate gene fate. An important result of this researh was the demonstration that in stem cells bivalent developmental genes are kept hypomethylated by DNMT3L to ensure epigenetic plasticity through cell differentiation. His laboratory set up a number of transcriptome-wide techniques (CIRS-seq, SPET-seq) to profile cellular RNA structure and genome-wide methods (MAB-seq) to map and measure 5-formylcytosine and 5-carboxylcytosine at single-base resolution. Using this method he could unveil the DNA methylation dynamics that take place in promoters of highly expressed genes. He also found that DNA methylation on the gene body, which is mediated by DNMT3b recruited by H3K36me3, ensures transcription initiation fidelity by preventing RNA Polymerase II to initiate the transcription outside the canonical promoter, avoiding aberrant transcription initiations.
Dr. Danial Kahrizi, Agronomy and Plant Breeding Dept., Razi University, Kermanshah, Iran
Danial Kahrizi is a professor of plant genetic engineering and molecular genetics at Razi University. He has been the head of Department of Plant Production and Genetics and head of Biotechnology Institute for Drought Research (BIDR) since 2003. In addition, He is the head and board chairman of Zagros Bioidea Co. He has authored or coauthored more than 120 journal articles, monographs, book chapters, and technical reports. He is Editor of Cellular and Molecular Biology in France. He has been editorial board membership of journals such as Gene, Plant Cell Reports and Molecular Biology Reports else. His interest is in plant genetic engineering, tissue culture and plant breeding (especially on oilseed plants such as Brassica napus and Camelina sativa) for drought tolerance. The first cultivar of Camelina has been released by Dr. Kahrizi in Iran. He produced more than 200 Camelina lines.
Uwe KORNAK, M.D. Ph.D., is leader of a research group on hereditary connective tissue disorders at the Institute of Medical Genetics and Human Genetics, Charité-Universitaetsmedizin Berlin and the Max Planck Institute for Molecular Genetics, Berlin, Germany.
During his Ph.D. training as a biochemist Uwe Kornak became involved in the generation and interdisciplinary analysis of in vitro and in vivo disease models for human disorders. Up to now he not only identified several genes associated with human disorders, but also analysed the effect of these gene defects using these disease models.
Through his work as a human geneticist he has a broad experience with clinical and molecular genetic diagnostics of rare human disorders with a special focus on rare musculoskeletal phenotypes as well as common osteoporosis. As a basic researcher he is most interested in understanding the cellular pathophysiology of progeroid hereditary disorders of the skeleton and of connective tissues. An important focus has always been the regulation of trafficking and ion homeostasis of intracellular compartments. During the last years Golgi-related disease processes have become a large research focus. Uwe Kornak has been reviewer for different human genetics journals and is board member of the German Society for Human Genetics.
Professor Fardin Fathi was born in Sanandaj, Iran. He studied anatomy at Tarbiat Modarres University and now is a full professor at Kurdistan University of Medical Sciences. He has started his research activity since 1380 and has published more than 50 papers in the field of stem cell biology and production of transgenic mice . He has established a center for stem cell research and producing transgenic mice in Kurdistan University of Medical Sciences. Dr fathi has produced various models of transgenic and knockout mice, including the first transgenic mous, the first cloned mouse and the first knockout mouse in Iran. He has passed three long-term training courses on stem cells and transgenic mice production in the Riken Institute of Japan and National center for producing transgenic mice in Czech Republic. Currently, his most research activity has been focused on the production of transgenic mice
Mohammad Javan is a Professor in Cellular and Molecular Physiology at Tarbiat Modares University in Tehran. Mohammad got his PhD from Shahid Beheshti University in Tehran and had his postdoctoral training at Kyorin University School of Medicine in Tokyo. He joined Tarbiat Modares University in 2004 and stablished his lab for myelin repair and axon protection. He holds a second affiliation in Royan Institute for Stem Cell Biology and Technology at department of Brain and Cognition ; as well as an associate membership at ICORD, University of British Columbia., He works on stem cell transplantation and on in vivo reprogramming of reactive astrocytes to myelinating cells and neurons. He is the council member of Iranian Society of Physiology and Pharmacology (ISPP) and the Editor in-chief of ISPP official English journal, Physiology and Pharmacology.
Andreas Börner received his PhD in Plant Breeding and Plant Genetics from the Martin-Luther-University, Halle-Wittenberg in 1988. Between 1990 and 1996 he was head of the research group Wheat Genetics of the Leibniz Institute of Plant Genetics and Crop Plant Research (IPK). He joined the Genebank of the IPK as the head of research group Resources Genetics and Reproduction in 1997. Since 2005 he has served as the head of program Management and Evaluation, which is responsible for the long term maintenance of the IPK Genebank collection of cultivated plants and their wild relatives. The Genebank is a major player in the global ex situ plant conservation effort, housing a wide spectrum of accessions representing most of the temperate crop species. In addition to his responsibility for the optimization of the management of the collection, he runs an active research program focused on the investigation of seed longevity, the study of the genetic integrity and genetic diversity as well as a comprehensive phenotypic (phenomic) and genetic description of materials related to the major temperate cereal crops. In close co-operation with many external partners segregation and association mapping populations are exploited to detect genes (QTLs) responsible for agronomic characters of interest.
Dr. Ramin Shiekhattar recently joined the University of Miami Miller School of Medicine as Professor in the Departments of Human Genetics and Biochemistry & Molecular Biology. He is also the Director of the Cancer Epigenetics Research Program, Chief of the Division of Cancer Genomics and Epigenetics as well as the academic Director of the Oncogenomic Core Facility. Dr. Shiekhattar obtained his Ph.D. degree from the University of Kansas and completed his postdoctoral training at UMDNJ.
Dr. Shiekhattar’s laboratory has made a number of important contributions over the past years in identifying and characterizing important mediators of epigenetic regulation and noncoding RNA processing that contribute to cancer development. Importantly, laboratories’ recent work has begun to explore a class of long noncoding RNAs (lncRNAs) that behave similar to transcriptional enhancers. The laboratory is interested in deciphering the function of this class of lncRNAs in the context of relevant models of development and disease, using state of the arts genomics and proteomics approaches. These data will be coupled with the development of novel computational methods to decipher the lncRNA “code” that helps to define the role of enhancer RNAs in development and disease.
Han Brunner pursues the scientific understanding of the connections between clinical and molecular features of rare diseases, including applications to patient care. He has pioneered the discovery of a large number of disease genes and the application of cutting-edge genomic technologies (genomic microarrays, exome sequencing, and whole genome sequencing) to discover the causes of genetic diseases. Much of this work focuses on neurodevelopmental conditions such as intellectual disability and abnormal behavior.
Han Brunner studied medicine at the University of Groningen 1975-1984. He trained as a clinical geneticist at Nijmegen University and was board certified in Clinical Genetics in 1988. In 1998 he was appointed full professor and head of department at the Radboud University Medical Center. As of January 2014 he has a joint appointment in Nijmegen at the department of Human Genetics in Nijmegen and in Maastricht at the department of Clinical Genetics.
Han Brunner was elected member of the Royal Netherlands Academy of Arts and Sciences in 2013 and of the Academia Europea in 2012. He is a Knight in the Order of the Dutch Lion since 2013. He is a co-winner of the King Faisal International Prize in Medicine 2016, with Joris Veltman. He is awarded the 2016 Carter medal of the British Clinical Genetics Society.
Prof. Ueli Grossniklaus Department of Plant and Microbial Biology University of Zürich.
My main research interest lies in developmental genetics. After obtaining a PhD in Drosophila developmental biology I switched to working with plants when I set up an independent research group at Cold Spring Harbor Laboratory in 1994. I used a recently established enhancer detection method in Arabidopsis to study plant reproductive biology, both sexual and asexual (apomixis). Our research focuses on the elucidation of the genetic basis and the molecular mechanisms underlying three major areas: i) embryo sac development and double fertilization, ii) the engineering of apomixis, and iii) the maternal control of early embryogenesis, which is largely mediated through epigenetic effects. Both genomic imprinting and Polycomb group complex-mediated repression play an important role in regulating seed development.
Professor Renier J. Brentjens, MD, PhD
Director, Cellular Therapeutics
Memorial Sloan Kettering Cancer Center, New York
I am a medical oncologist specializing in the treatment of acute and chronic leukemias. My focus on leukemia is, in part, the result of the laboratory research I conduct at Memorial Sloan Kettering Cancer Center. In particular, my laboratory is focused on developing novel treatment approaches for certain leukemias and lymphomas utilizing the patient’s own immune system. Specifically this work involves the genetic manipulation of patients’ immune cells to recognize and kill their own cancer cells. This is a promising form of gene therapy.
In light of encouraging results in mouse studies, we are now testing this approach at Memorial Sloan Kettering in patients with chronic lymphocytic leukemia (CLL) who are no longer responsive to chemotherapy. We hope to set up a similar study for patients with recurrent acute lymphoblastic leukemia in the near future. These highly innovative studies will hopefully result in a novel and successful treatment option for patients with certain forms of hematologic cancers.
Professor Mehdi Hosseini-Mazinani,
Director of olive research team, Department of Plant Molecular Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
The olive research team at the National Institute of Genetic Engineering and Biotechnology (NIGEB) in collaboration with the Ministry of Agriculture and different national and international organizations has been investigating Iranian olive gene pool for more than 15 years. My research team focus on evaluation, conservation and utilization of olive genetic resources in Iran. We have developed different molecular approaches to detect genetic diversity and the origin of olive population in Iran also documented in "Iranian Olive Catalogue" (selected as the best book in the field of horticultural science, 2014) and reported in several peer-reviewed papers. We have studied genes involved in oil syntheses and root formation in different olive varieties and we have identified and characterized three different SAD genes which are involved in fatty acid syntheses in olive trees. We have also identified polymorphism in AOX2 genes associated with the rooting ability of different olive varieties. We are now interested in applying next generation sequencing method for rapid marker development in molecular breeding of olive. This method can also be applied to compare SNP diversity within and between olive populations.
Dr. SM Kalantar is an academic member of Yazd Medical Sciences University as Prof. in Dept. of Medical Genetic. He is also Director of the Reproductive & Genetic Unit (RGU) of the Institute of Reproductive Biology of Yazd Medical Sciences University. He obtained his PhD from Dept. of Obs. &Gyn. (Sheffield Fertility Centre) in conjunction with Dept. of Molecular Biology & Biotechnology, Sheffield University. His training and researches continued at Yorkhill Children Hospital (molecular cytogenetic Lab), Glasgow and Pavia University, Italy. RGU is focused on Genetic aspects of Reproductive Medicine especially on male & female infertility, also Repeated Pregnancy Loss. During last two decade several projects were run and published related to the field. Recently a project is conducted with collaborating of the other center in the Institute on stem cells from Amniotic fluid to be used for Regenerative Medicine.
Seyyed Abolghasem Mohammadi is a Professor of Genetics and Genomics at the Department of Plant Breeding and Biotechnology, Faculty of Agriculture, University of Tabriz, Iran. He is also head of the Center of Excellence in Cereal Molecular Breeding. His research is focused on the genetic control of complex traits in cereal crops specially wheat under changing environments. Mohammadi is interested in applying genomic tools and techniques to map genes and QTLs to development new high yielding wheat genotypes resistant to biotic and abiotic stresses. In collaboration with national and international institutes, his group developed several bi-parental populations and association panels using elite and landrace germplasms to detect genes (QTLs) responsible for traits of interest in wheat.
Dr. Mehri Haeili earned her Ph.D in Microbiology from the University of Tehran, Iran in 2014. She joined the Department of Infectious Diseases at the University of Alabama at Birmingham, USA as research assistant and worked on the development and discovery of novel anti-tuberculosis compounds. After completion of her degree she served as assistant professor at the University of Tabriz from 2015. Her interests are focused on molecular mechanisms of antibiotic resistance in bacteria. In particular, her laboratory is currently working on unravelling the molecular determinants of resistance to last-hope Gram- negative antibacterials including colistin and carbapenems.
Professor Khleskina Elena
Director of the N.I. Vavilov All-Russian Research Institute of Plant Genetic Resources (VIR), St. Petersburg, Russia.
Elena K Khlestkina currently works at the N.I. Vavilov All-Russian Research Institute of Plant Genetic Resources. Elena does research in Plant Genetics. Her most recent publication is 'Anthocyanins participate in the protection of wheat seedlings against cadmium stress'.
N.I. Vavilov All-Russian Research Institute of Plant Genetic Resources
Russia · St. Peterburg
Novosibirsk State University · Food Security Research Center
Russia · Novosibirsk
Oct 1998–Feb 2018
Institute of Cytology and Genetics · Cereal Functional Genetics · Cereal Functional Genetics Group
Russia · Novosibirsk
Dr: Alireza Ehsani
Department of Animal Science, Tarbiat Modares University
Saman Hosseinkhani is currently Professor of Biochemistry at Tarbiat Modares University. He received his B.Sc. in Cell and Molecular Biology from Shiraz University. He also received his PhD in Biochemistry from University of Tehran in 2002. He joined Department of Biochemistry, Tarbiat Modares University in 2003. His research career is mainly focused on protein engineering of firefly luciferase and its application as a gene reporter within biological system. His recent work is mainly focused on development of reporter gene assay for targeting protein complexes in different cell death modalities and also discrimination of apoptotic pathway from stem cell development using new luciferase-based gene reporter assays. Moreover, “peptideticle” structures have been designed for gene delivery based on luciferase assay.
He has published 190 international peer-reviewed article, 3 reviews in international journals, and contribution in six books in Persian. He has received different international and national awards including young scientist (IUBMB, 2005), and Razi medical award.
ایران در طول 2 دهه ی گذشته، تقریبا در تمامی جنبه های علم ژنتیک، در زمینه ی علوم و تکنولوژی پیشرفت های قابل توجهی داشته است.به همین منظور ما مفتخریم تا برگزاری کنگره ژنتیک در تهران، ایران، در سال 1397 را اعلام داریم. سومین کنگره بین المللی و پانزدهمین کنگره ملی ژنتیک ایران در تاریخ 25-23 اردیبهشت ماه 1397 در تهران، ایران برگزار خواهد شد.کنگره به میزبانی انجمن ژنتیک ایران می باشد.
دفتر ثبت نام:
دانشگاه تربیت مدرس- دانشکده علوم زیستی - ط 5 - اتاق 5601 دبیرخانه کنگره ژنتیک ایران
شماره تلفن کنگره: 82884745
فکس کنگره: 89787971